A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
Completed · Phase 2 · Has a placebo group
Conditions studied: Obesity
In brief
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07976016) for the potential treatment of obesity. The study will compare the experiences of participants taking the study medicine (PF-07976016) to those of participants who take placebo (a lookalike substance that contains no active study medicine). The aim is to measure the body's response to the study medicine, including any changes in participants' body weight and how well they tolerate the study medicine.
Key facts
- Study ID
- NCT06717425
- Run by
- Pfizer
- People needed
- 263
- Starts
- 2024-12-09
- Expected to finish
- 2026-01-12
- Last updated by the study team
- 2026-02-06
Who can join
Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Anaheim Clinical Trials, LLC — Anaheim, California, United States
- Artemis Institute for Clinical Research — San Diego, California, United States
- Clinical & Translational Research Center — Aurora, Colorado, United States
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
- Westside Center for Clinical Research — Jacksonville, Florida, United States
- New Horizon Research Center — Miami, Florida, United States
- Renstar Medical Research — Ocala, Florida, United States
- Renstar Medical Research — Ocala, Florida, United States
- St Johns Center for Clinical Research — Saint Augustine, Florida, United States
- Rophe Adult and Pediatric Medicine/SKYCRNG — Union City, Georgia, United States
- East-West Medical Research Institute — Honolulu, Hawaii, United States
- Cotton O'Neil Diabetes & Endocrinology — Topeka, Kansas, United States
- L-MARC Research Center — Louisville, Kentucky, United States
- Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States
- StudyMetrix Research — City of Saint Peters, Missouri, United States
- Rochester Clinical Research, LLC — Rochester, New York, United States
- Accellacare - Wilmington — Wilmington, North Carolina, United States
- AMR Clinical — Norman, Oklahoma, United States
- Cornerstone Nutrition and Diabetes — Norman, Oklahoma, United States
- Capital Area Research, LLC — Camp Hill, Pennsylvania, United States
- Elligo Clinical Research Center — Austin, Texas, United States
- Texas Diabetes & Endocrinology, P.A. — Austin, Texas, United States
- Velocity Clinical Research, Dallas — Dallas, Texas, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
- Consano Clinical Research, LLC — Shavano Park, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.